Number of the records: 1

sialoglykoproteíny

	MeSH Tree Structures - sialoglykoproteíny `[d09.400.430.950]` sacharidy [d09] + glykokonjugáty [d09.400] + glykoproteíny [d09.400.430] + aktivíny [d09.400.430.250] + ADAM proteíny [d09.400.430.500] + alfa 1-antichymotrypsín [d09.400.430.563] alfa 1-antitrypsín [d09.400.430.594] alfa-2-antiplazmín [d09.400.430.610] alfa-2-HS-glykoproteín [d09.400.430.618] hormón anti-Müllerov [d09.400.430.625] asialoglykoproteíny [d09.400.430.657] avidín [d09.400.430.673] faktor aktivujúci B-bunky [d09.400.430.681] ligand 4-1BB [d09.400.430.685] beta 2-glykoproteín I [d09.400.430.687] ligand CD27 [d09.400.430.688] proteíny transportujúce estery cholesterolu [d09.400.430.700] klusterín [d09.400.430.750] faktory stimulujúce kolónie [d09.400.430.775] + proteín inhibujúci komplement C1 [d09.400.430.780] fibrilíny [d09.400.430.800] + proteíny glykované [d09.400.430.825] + glykodelín [d09.400.430.850] hemopexín [d09.400.430.860] proteíny teplotného šoku HSP47 [d09.400.430.870] inhibíny [d09.400.430.883] + laktoferín [d09.400.430.887] glykoproteíny membránové [d09.400.430.890] + mukoproteíny [d09.400.430.900] + proteín myelínový P0 [d09.400.430.910] osteonektín [d09.400.430.912] proteín C [d09.400.430.915] proteín S [d09.400.430.920] proteoglykány [d09.400.430.930] + komponent sérového amyloidu P [d09.400.430.940] sialoglykoproteíny `[d09.400.430.950]` leukosialín [d09.400.430.950.174] glykoforíny [d09.400.430.950.350] sialoproteín viažuci integrín [d09.400.430.950.675] osteopontín [d09.400.430.950.837] tyreoglobulín [d09.400.430.952] proteíny viažuce tyroxín [d09.400.430.955] + transkortín [d09.400.430.960] faktor nekrotizujúci nádory, alfa [d09.400.430.965] vitronektín [d09.400.430.982] Zn-alfa-2-glykoproteín [d09.400.430.998]
	`[d12.644.233.800]` aminokyseliny, peptidy a proteíny [d12] + peptidy [d12.644] + glykopeptidy [d12.644.233] + acetylmuramyl-alanyl-izoglutamín [d12.644.233.050] bleomycín [d12.644.233.110] + lipoglykopeptidy [d12.644.233.352] + peptidoglykán [d12.644.233.594] ristocetín [d12.644.233.697] sialoglykoproteíny `[d12.644.233.800]` leukosialín [d12.644.233.800.174] glykoforíny [d12.644.233.800.350] vankomycín [d12.644.233.925]
	`[d12.776.395.700]` aminokyseliny, peptidy a proteíny [d12] + proteíny [d12.776] + glykoproteíny [d12.776.395] + aktivíny [d12.776.395.022] + ADAM proteíny [d12.776.395.033] + alfa 1-antichymotrypsín [d12.776.395.045] alfa 1-antitrypsín [d12.776.395.068] alfa-2-antiplazmín [d12.776.395.080] alfa-2-HS-glykoproteín [d12.776.395.086] hormón anti-Müllerov [d12.776.395.089] ligand CD27 [d12.776.395.092] asialoglykoproteíny [d12.776.395.140] avidín [d12.776.395.175] faktor aktivujúci B-bunky [d12.776.395.191] ligand 4-1BB [d12.776.395.192] beta 2-glykoproteín I [d12.776.395.195] proteíny transportujúce estery cholesterolu [d12.776.395.199] klusterín [d12.776.395.207] faktory stimulujúce kolónie [d12.776.395.240] + proteín inhibujúci komplement C1 [d12.776.395.320] fibrilíny [d12.776.395.341] + proteíny glykované [d12.776.395.351] + glykodelín [d12.776.395.361] hemopexín [d12.776.395.401] proteíny teplotného šoku HSP47 [d12.776.395.420] inhibíny [d12.776.395.439] + laktoferín [d12.776.395.507] glykoproteíny membránové [d12.776.395.550] + mukoproteíny [d12.776.395.560] + proteín myelínový P0 [d12.776.395.570] osteonektín [d12.776.395.600] proteín C [d12.776.395.635] proteín S [d12.776.395.642] proteoglykány [d12.776.395.650] + komponent sérového amyloidu P [d12.776.395.690] sialoglykoproteíny `[d12.776.395.700]` leukosialín [d12.776.395.700.174] glykoforíny [d12.776.395.700.350] sialoproteín viažuci integrín [d12.776.395.700.675] osteopontín [d12.776.395.700.837] tyreoglobulín [d12.776.395.768] proteíny viažuce tyroxín [d12.776.395.832] + transkortín [d12.776.395.901] faktor nekrotizujúci nádory, alfa [d12.776.395.930] vitronektín [d12.776.395.970] Zn-alfa-2-glykoproteín [d12.776.395.985]
Sign.	C 3004
Source	Lekárnické listy : odborno-informačný časopis Slovenskej lekárnickej komory. - ISSN 1335-5821. - Bratislava : Edufarm , 2021 . - Roč. 23, č. 4 (2021), s. 32-33 : ilustr., fareb., obr., tab.
MeSH Subject	svetlo : účinky nežiaduce poruchy zaspávania a udržiavania spánku : terapia prípravky farmaceutické

subject heading

subject heading

Number of the records: 1

For full functionality of this site it is necessary to enable JavaScript. Here are the instructions how to enable JavaScript in your web browser.